1887

Abstract

A natural type 3/type 2 intertypic capsid recombinant vaccine-related poliovirus was isolated from an acute flaccid paralytic case in Brazil. Genome sequencing revealed the uncommon location of the crossover site in the VP1 coding region (nucleotides 3251–3258 of Sabin 3 genome). The Sabin 2 donor sequence replaced the last 118 nt of VP1, resulting in the substitution of the complete antigenic site IIIa by PV2-specific amino acids. The low overall number of nucleotide substitutions in P1 region indicated that the predicted replication time of the isolate was about 8–9 weeks. Two of the principal determinants of attenuation in Sabin 3 genomes were mutated (U472C and C2493U), but the temperature-sensitive phenotype of the isolate was preserved. Our results support the theory that there exists a PV3/PV2 recombination hotspot site in the tail region of the VP1 capsid protein and that the recombination may occur soon after oral poliovirus vaccine administration.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000484
2016-07-01
2021-07-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/7/1545.html?itemId=/content/journal/jgv/10.1099/jgv.0.000484&mimeType=html&fmt=ahah

References

  1. Blomqvist S., Bruu A. L., Stenvik M., Hovi T. 2003; Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J Gen Virol 84:573–580 [View Article][PubMed]
    [Google Scholar]
  2. Blomqvist S., Savolainen-Kopra C., Paananen A., El Bassioni L., El Maamoon Nasr E. M., Firstova L., Zamiatina N., Kutateladze T., Roivainen M. 2010; Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1. Virus Res 151:246–251 [View Article][PubMed]
    [Google Scholar]
  3. Cai J. J., Smith D. K., Xia X., Yuen K. Y. 2005; MBEToolbox: a MATLAB toolbox for sequence data analysis in molecular biology and evolution. BMC Bioinformatics 6:64 [View Article][PubMed]
    [Google Scholar]
  4. Cai J. J., Smith D. K., Xia X., Yuen K. Y. 2007; MBEToolbox 2.0: an enhanced version of a MATLAB toolbox for molecular biology and evolution. Evol Bioinform Online 2:179–182[PubMed]
    [Google Scholar]
  5. Centers for Disease Control and Prevention (CDC) 2009; Laboratory surveillance for wild and vaccine-derived polioviruses - worldwide, January 2008-June 2009. MMWR Morb Mortal Wkly Rep 58:950–9954[PubMed]
    [Google Scholar]
  6. Cuervo N. S., Guillot S., Romanenkova N., Combiescu M., Aubert-Combiescu A., Seghier M., Caro V., Crainic R., Delpeyroux F. 2001; Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees. J Virol 75:5740–5751 [View Article][PubMed]
    [Google Scholar]
  7. Dedepsidis E., Pliaka V., Kyriakopoulou Z., Brakoulias C., Levidiotou-Stefanou S., Pratti A., Mamuris Z., Markoulatos P. 2008; Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant. FEMS Immunol Med Microbiol 52:343–351 [View Article][PubMed]
    [Google Scholar]
  8. Dedepsidis E., Kyriakopoulou Z., Pliaka V., Markoulatos P., Markoulatos P. 2010; Correlation between recombination junctions and RNA secondary structure elements in poliovirus Sabin strains. Virus Genes 41:181–191 [View Article][PubMed]
    [Google Scholar]
  9. Egger D., Bienz K. 2002; Recombination of poliovirus RNA proceeds in mixed replication complexes originating from distinct replication start sites. J Virol 76:10960–10971[PubMed] [CrossRef]
    [Google Scholar]
  10. Goldman N., Yang Z. 1994; A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol Biol Evol 11:725–736[PubMed]
    [Google Scholar]
  11. Hall T. A. 1999; BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98
    [Google Scholar]
  12. Jorba J., Campagnoli R., De L., Kew O. 2008; Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol 82:4429–4440 [View Article][PubMed]
    [Google Scholar]
  13. Karakasiliotis I., Markoulatos P., Katsorchis T., Markoulatos P., Katsorchis T. 2004; Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees. Mol Cell Probes 18:103–109 [View Article][PubMed]
    [Google Scholar]
  14. Kohara M., Omata T., Kameda A., Semler B. L., Itoh H., Wimmer E., Nomoto A. 1985; In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol 53:786–792[PubMed]
    [Google Scholar]
  15. Kohara M., Abe S., Komatsu T., Tago K., Arita M., Nomoto A. 1988; A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J Virol 62:2828–2835[PubMed]
    [Google Scholar]
  16. Lole K. S., Bollinger R. C., Paranjape R. S., Gadkari D., Kulkarni S. S., Novak N. G., Ingersoll R., Sheppard H. W., Ray S. C. 1999; Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73:152–160[PubMed]
    [Google Scholar]
  17. Macadam A. J., Arnold C., Howlett J., John A., Marsden S., Taffs F., Reeve P., Hamada N., Wareham K. et al. 1989; Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology 172:408–414 [View Article][PubMed]
    [Google Scholar]
  18. Martín J., Samoilovich E., Dunn G., Lackenby A., Feldman E., Heath A., Svirchevskaya E., Cooper G., Yermalovich M. et al. 2002; Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J Virol 76:10921–10928[PubMed] [CrossRef]
    [Google Scholar]
  19. Minor P. D., Ferguson M., Evans D. M., Almond J. W., Icenogle J. P. 1986; Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol 67:1283–1291 [View Article][PubMed]
    [Google Scholar]
  20. Minor P. D., Dunn G., Evans D. M., Magrath D. I., John A., Howlett J., Phillips A., Westrop G., Wareham K. et al. 1989; The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. J Gen Virol 70:1117–1123 [View Article][PubMed]
    [Google Scholar]
  21. Minor P. D. 1992; The molecular biology of poliovaccines. J Gen Virol 73:3065–3077 [View Article][PubMed]
    [Google Scholar]
  22. Minor P. D. 1993; Attenuation and reversion of the Sabin vaccine strains of poliovirus. Dev Biol Stand 78:17–26[PubMed]
    [Google Scholar]
  23. Mueller J. E., Bessaud M., Huang Q. S., Martinez L. C., Barril P. A., Morel V., Balanant J., Bocacao J., Hewitt J. et al. 2009; Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina. Appl Environ Microbiol 75:1395–1401 [View Article][PubMed]
    [Google Scholar]
  24. Nakano J. H., Hatch M. H., Thieme M. L., Nottay B., Milford M. H. 1978; Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog Med Virol 24:178–206[PubMed]
    [Google Scholar]
  25. Paximadi E., Karakasiliotis I., Mamuris Z., Stathopoulos C., Krikelis V., Markoulatos P. 2006; Genomic analysis of recombinant Sabin clinical isolates. Virus Genes 32:203–210 [View Article][PubMed]
    [Google Scholar]
  26. Pliaka V., Kyriakopoulou Z., Tsakogiannis D., Ruether I. G., Gartzonika C., Levidiotou-Stefanou S., Krikelis A., Markoulatos P., Ruether I. G. 2010; Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains. Eur J Clin Microbiol Infect Dis 29:1513–1523 [View Article][PubMed]
    [Google Scholar]
  27. Rezapkin G. V., Norwood L. P., Taffs R. E., Dragunsky E. M., Levenbook I. S., Chumakov K. M. 1995; Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Virology 211:377–384 [View Article][PubMed]
    [Google Scholar]
  28. Rico-Hesse R., Pallansch M. A., Nottay B. K., Kew O. M. 1987; Geographic distribution of wild poliovirus type 1 genotypes. Virology 160:311–322 [View Article][PubMed]
    [Google Scholar]
  29. Savolainen-Kopra C., Blomqvist S. 2010; Mechanisms of genetic variation in polioviruses. Rev Med Virol 20:358–371 [View Article][PubMed]
    [Google Scholar]
  30. Simmonds P., Welch J. 2006; Frequency and dynamics of recombination within different species of human enteroviruses. J Virol 80:483–493 [View Article][PubMed]
    [Google Scholar]
  31. Simon-Loriere E., Holmes E. C. 2011; Why do RNA viruses recombine?. Nat Rev Microbiol 9:617–626 [View Article][PubMed]
    [Google Scholar]
  32. Tamura K. 1992; Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G+C-content biases. Mol Biol Evol 9:678–687[PubMed]
    [Google Scholar]
  33. Tamura K., Stecher G., Peterson D., Filipski A., Kumar S. 2013; MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30:2725–2729 [View Article][PubMed]
    [Google Scholar]
  34. Tao Z., Wang H., Xu A., Zhang Y., Song L., Zhu S., Li Y., Yan D., Liu G. et al. 2010; Isolation of a recombinant type 3/type 2 poliovirus with a chimeric capsid VP1 from sewage in Shandong, China. Virus Res 150:56–60 [View Article][PubMed]
    [Google Scholar]
  35. Westrop G. D., Wareham K. A., Evans D. M., Dunn G., Minor P. D., Magrath D. I., Taffs F., Marsden S., Skinner M. A. et al. 1989; Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol 63:1338–1344[PubMed]
    [Google Scholar]
  36. World Health Organization 2004 Polio Laboratory Manual WHO/IVB/04, 4th edn. Geneva, Switzerland: World Health Organization;
    [Google Scholar]
  37. World Health Organization, Vaccine and Biologicals. Global Poliomyelitis Eradication Initiative 2006; Polio Lab Network Quartely Update. New test algorithm to be implemented in 2007. XIIIissue 4 Available at: http://apps.who.int/immunization_monitoring/VolXIIIDec06.pdf?ua=1
  38. Zhang Y., Zhu S., Yan D., Liu G., Bai R., Wang D., Chen L., Zhu H., An H. et al. 2010; Natural type 3/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region. PLoS One 5:e15300 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000484
Loading
/content/journal/jgv/10.1099/jgv.0.000484
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error